Shaul Lev-Ran

Summary

Publications

  1. ncbi request reprint [Motivational interviewing in health care]
    Shaul Lev-Ran
    Shalvata Mental Health Center, Hod Hasharon, Israel
    Harefuah 150:733-6, 749. 2011
  2. ncbi request reprint Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates
    Shaul Lev-Ran
    Social Aetiology of Mental Illness SAMI CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Addictions Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Electronic address
    Psychiatry Res 209:459-65. 2013
  3. doi request reprint Cannabis use and cannabis use disorders among individuals with mental illness
    Shaul Lev-Ran
    Social Aetiology of Mental Illness CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Compr Psychiatry 54:589-98. 2013
  4. doi request reprint Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC)
    Shaul Lev-Ran
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Am J Addict 22:93-8. 2013
  5. ncbi request reprint A case of treating cathinone dependence and comorbid depression using bupropion
    Shaul Lev-Ran
    Department of Psychiatry, Sheba Medical Center, Tel Hashomer, Israel
    J Psychoactive Drugs 44:434-6. 2012
  6. doi request reprint Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample
    Shaul Lev-Ran
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Am J Addict 22:7-13. 2013
  7. doi request reprint Attitudes towards nicotine, alcohol and drug dependence among physicians in Israel
    Shaul Lev-Ran
    Shalvata Mental Health Center, Hod Hasharon, 45100, Israel
    J Subst Abuse Treat 44:84-9. 2013
  8. doi request reprint Cannabis use and mental health-related quality of life among individuals with anxiety disorders
    Shaul Lev-Ran
    Social Aetiology of Mental Illness SAMI CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    J Anxiety Disord 26:799-810. 2012
  9. doi request reprint Clinical correlates of cannabis use among adolescent psychiatric inpatients
    S Lev-Ran
    Shalvata Mental Health Center, POB 94 Hod Hasharon, 45100, Israel
    Eur Psychiatry 27:470-5. 2012
  10. doi request reprint Neurocognitive functions of heavy cannabis using schizophrenia patients
    S Lev-Ran
    Cognitive and Emotional Laboratory, Shalvata Mental Health Center, Hod Hasharon, Israel
    Eur Psychiatry 27:365-8. 2012

Detail Information

Publications19

  1. ncbi request reprint [Motivational interviewing in health care]
    Shaul Lev-Ran
    Shalvata Mental Health Center, Hod Hasharon, Israel
    Harefuah 150:733-6, 749. 2011
    ..Thus, motivational interviewing helps patients adopt a healthier lifestyle while contributing to the professionalism of physicians and their sense of satisfaction from work...
  2. ncbi request reprint Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates
    Shaul Lev-Ran
    Social Aetiology of Mental Illness SAMI CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Addictions Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Electronic address
    Psychiatry Res 209:459-65. 2013
    ..Comprehensive evaluation of patients with bipolar disorder should include a systematic assessment of CUD. ..
  3. doi request reprint Cannabis use and cannabis use disorders among individuals with mental illness
    Shaul Lev-Ran
    Social Aetiology of Mental Illness CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Compr Psychiatry 54:589-98. 2013
    ..However, this subject has not been sufficiently investigated, particularly given limitations in diagnostic tools used and lack of data pertaining to frequency of cannabis used...
  4. doi request reprint Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC)
    Shaul Lev-Ran
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Am J Addict 22:93-8. 2013
    ..This may be important as increased prevalence of substance use among individuals with MI may partially explain the strong association between SUDs and MI...
  5. ncbi request reprint A case of treating cathinone dependence and comorbid depression using bupropion
    Shaul Lev-Ran
    Department of Psychiatry, Sheba Medical Center, Tel Hashomer, Israel
    J Psychoactive Drugs 44:434-6. 2012
    ..Clinical awareness to the addictive potential of cathinone and cathinone-derivatives is important. Research regarding the potential effectiveness of bupropion in these cases is needed...
  6. doi request reprint Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample
    Shaul Lev-Ran
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Am J Addict 22:7-13. 2013
    ..In this study, we explored gender differences in prevalence of SUDs among individuals with lifetime exposure to substances using a single diagnostic category (abuse or dependence)...
  7. doi request reprint Attitudes towards nicotine, alcohol and drug dependence among physicians in Israel
    Shaul Lev-Ran
    Shalvata Mental Health Center, Hod Hasharon, 45100, Israel
    J Subst Abuse Treat 44:84-9. 2013
    ..Physicians' attitudes towards addictions have a significant role in the care that clients with addictions receive. Medical education programs in Israel should devote provisions towards educating physicians about addictions...
  8. doi request reprint Cannabis use and mental health-related quality of life among individuals with anxiety disorders
    Shaul Lev-Ran
    Social Aetiology of Mental Illness SAMI CIHR Training Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    J Anxiety Disord 26:799-810. 2012
    ..Out results highlight the importance of taking into account direct functional and emotional outcomes, as well as frequency of cannabis used, when assessing the impact of cannabis use among individuals with anxiety disorders...
  9. doi request reprint Clinical correlates of cannabis use among adolescent psychiatric inpatients
    S Lev-Ran
    Shalvata Mental Health Center, POB 94 Hod Hasharon, 45100, Israel
    Eur Psychiatry 27:470-5. 2012
    ..This study sought to determine the clinical correlates of adolescents with cannabis use and no additional drug use (CU) compared to adolescents with no drug use (NDU) among a group of adolescent psychiatric inpatients in Israel...
  10. doi request reprint Neurocognitive functions of heavy cannabis using schizophrenia patients
    S Lev-Ran
    Cognitive and Emotional Laboratory, Shalvata Mental Health Center, Hod Hasharon, Israel
    Eur Psychiatry 27:365-8. 2012
    ..Cannabis using schizophrenia patients had focused impairments on tasks of attention, and the findings suggest an impulsive pattern of response among these patients...
  11. doi request reprint Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions
    Shaul Lev-Ran
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada
    Drug Alcohol Depend 123:190-200. 2012
    ..Cannabis is the most widely used illicit substance worldwide. The aim of the present study was to assess self-reported Quality of Life (QoL) among cannabis users in a large representative sample...
  12. doi request reprint Contributions of a relational psychoanalytic approach to dealing with the nonadherent psychiatric patient
    Shaul Lev-Ran
    Shalvata Mental Health Center, Hod Hasharon, Israel
    Bull Menninger Clin 75:281-94. 2011
    ..A clinical vignette is presented, by which these points are illustrated and defined...
  13. ncbi request reprint Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review
    Shaul Lev-Ran
    Translational Addiction Research Laboratory, Addictions Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Can J Psychiatry 57:342-9. 2012
    ..Several prevalent psychiatric disorders have not been studied when co-occurring with AUDs. Further research of pharmacological treatments for concurrent AUDs and psychiatric diagnoses is urgently needed...
  14. doi request reprint Self-reported psychotic disorders among Individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions
    Shaul Lev-Ran
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    Am J Addict 21:531-5. 2012
    ..Most reports to-date focus on the prevalence of SUDs among clinical populations of patients with PDs, and there is a lack of data pertaining to rates of PDs among individuals with substance use and SUDs...
  15. doi request reprint Consenting not to be informed: a survey on the acceptability of placebo use in the treatment of depression
    Uri Nitzan
    Shalvata Mental Health Center, Hod Hasharon, Israel
    J Nerv Ment Dis 201:345-7. 2013
    ..Additional studies on the possible use of placebo as an effective, safe, and acceptable form of therapy are warranted...
  16. pmc Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used
    Bernard Le Foll
    Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Canada
    Int J Neuropsychopharmacol 15:1265-74. 2012
    ..The ability of varenicline to reduce both nicotine-taking and nicotine-seeking behaviour can contribute to its relatively high efficacy in treating human smokers...
  17. ncbi request reprint Neurocognitive functioning and cannabis use in schizophrenia
    Aviv Segev
    Shalvata Mental Health Center, POB 94, Hod Hasharon, Israel
    Curr Pharm Des 18:4999-5007. 2012
    ..These methodological issues are discussed, as well as possible explanations for the results presented and suggestions for future research in this field...
  18. ncbi request reprint Internet-related psychosis−a sign of the times
    Uri Nitzan
    Shalvata Mental Health Care Center, Hod Hasharon, Israel, affiliated to the Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel
    Isr J Psychiatry Relat Sci 48:207-11. 2011
    ..This papers aim is to call attention to computer mediated communication (CMC), such as Facebook or chats, and alert to its possible relation to psychosis...
  19. ncbi request reprint [Forced medical treatment: existent law and its limitations in a general hospital]
    Uri Nitzan
    Shalvata Mental Health Care Center, Hod Hasharon, Israel
    Harefuah 150:397-400, 416. 2011
    ..Finally, we raise a few ideas as to how the present condition can be improved...